Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting
- 1 January 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 123 (1), 79-86
- https://doi.org/10.1161/circulationaha.110.966879
Abstract
Background—: It is unknown whether the preferred 1-stent bifurcation stenting approach with stenting of the main vessel (MV) and optional side branch stenting using drug-eluting stents should be finalized by a kissing balloon dilatation (FKBD). Therefore, we compared strategies of MV stenting with and without FKBD. Methods and Results—: We randomized 477 patients with a bifurcation lesion to FKBD (n=238) or no FKBD (n=239) after MV stenting. The primary end point was major adverse cardiac events: cardiac death, non–procedure-related index lesion myocardial infarction, target lesion revascularization, or stent thrombosis within 6 months. The 6-month major adverse cardiac event rates were 2.1% and 2.5% ( P =1.00) in the FKBD and no-FKBD groups, respectively. Procedure and fluoroscopy times were longer and more contrast media was needed in the FKBD group than in the no-FKBD group. Three hundred twenty-six patients had a quantitative coronary assessment. At 8 months, the rate of binary (re)stenosis in the entire bifurcation lesion (MV and side branch) was 11.0% versus 17.3% ( P =0.11), in the MV was 3.1% versus 2.5% ( P =0.68), and in the side branch was 7.9% versus 15.4% ( P =0.039) in the FKBD versus no-FKBD groups, respectively. In patients with true bifurcation lesions, the side branch restenosis rate was 7.6% versus 20.0% ( P =0.024) in the FKBD and no-FKBD groups, respectively. Conclusions—: MV stenting strategies with and without FKBD were associated with similar clinical outcomes. FKBD reduced angiographic side branch (re)stenosis, especially in patients with true bifurcation lesions. The simple no-FKBD procedures resulted in reduced use of contrast media and shorter procedure and fluoroscopy times. Long-term data on stent thrombosis are needed. Clinical Trial Registration—: URL: http://clinicaltrials.gov . Unique identifier: NCT00914199.Keywords
This publication has 16 references indexed in Scilit:
- Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation LesionsCirculation, 2010
- Intervencionismo coronario percutáneo en lesiones en bifurcación. ¿Puede su clasificación ayudar a seleccionar la estrategia terapéutica?Revista Espanola de Cardiologia, 2009
- Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary BifurcationsCirculation, 2009
- Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesionsEuropean Heart Journal, 2008
- Bifurcation Disease: What Do We Know, What Should We Do?КАРДИОЛОГИЯ УЗБЕКИСТАНА, 2008
- Clinical End Points in Coronary Stent TrialsCirculation, 2007
- Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)American Heart Journal, 2006
- Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation LesionsCirculation, 2006
- Contemporary Stent Treatment of Coronary BifurcationsJournal of the American College of Cardiology, 2005
- Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique: Importance of Final Kissing Balloon Post-DilationJournal of the American College of Cardiology, 2005